1BP-LSD Facts
Psychedelic;
Description
1BP-LSD (1-boronobenzoyl-lysergic acid diethylamide) is a synthetic psychedelic of the lysergamide class. It activates serotonin receptors in the brain, producing the visual and cognitive shifts characteristic of classical psychedelics.[1]
Subjective effects include geometric visual patterns, brightened colors, thought connectivity, emotional intensification, and ego dissolution. The experience mirrors LSD — expansive, stimulant-edged, and mentally sharp — but arrives through a slow come-up that can stretch two or more hours.[2]
1BP-LSD produces no physical dependence, and no death has been attributed to its active metabolite LSD.[3] The primary danger is psychological — high doses in unsupported settings can trigger acute panic, and people with a personal or family history of psychosis face disproportionate risk of lasting destabilization.[4]
Dose and durationby route · individual sensitivity varies
Starts in 60 – 120 minLasts 10 – 14 hoursAfter-effects 12 – 48 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Low
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 10 days
- Carries over to
- LSD;
psilocybin; DMT; mescaline; 1P-LSD; 1B-LSD; 1cP-LSD; 1V-LSD; 1S-LSD
Effectslikely at a common dose
- Perception
- Color alteration;
Color enhancement; Geometry; Music enhancement; Visual breathing; Visual drifting; +33 possible, including Spatial disorientation, Vestibular distortion, Visual haze / noise - Body
- Body scan awareness;
Insomnia; Pupil dilation; Stimulation; Wakefulness; +31 possible, including Heart rate perception changes, Muscle tension, Dizziness - Thinking
- Aesthetic enhancement;
Introspection enhancement; Openness enhancement; +34 possible, including Decision impairment, Suggestibility enhancement, Thought loops - Feeling
- Emotional enhancement;
+10 possible, including Emotional lability, Anxiety, Paranoia - Self
- none likely · 12 possible, including Derealization, Depersonalization, Ego inflation
- Time
- Time alteration;
+4 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 6 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Holze F, Vizeli P, Müller F, Ley L, Duerig R, Varghese N, Zizzari P, Liechti ME (2021) Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects — Neuropsychopharmacology doi:10.1038/s41386-020-00883-6
- [2]
- [3]
- [4]^Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ (2022) Adverse effects of psychedelics: From anecdotes and misinformation to systematic science — Journal of Psychopharmacology doi:10.1177/02698811211069100